Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 17 |
NetGPI | no | yes: 0, no: 17 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005759 | mitochondrial matrix | 5 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0035770 | ribonucleoprotein granule | 3 | 1 |
GO:0043226 | organelle | 2 | 2 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0099080 | supramolecular complex | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4HNQ2
Term | Name | Level | Count |
---|---|---|---|
GO:0000959 | mitochondrial RNA metabolic process | 6 | 2 |
GO:0000963 | mitochondrial RNA processing | 6 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009894 | regulation of catabolic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 2 |
GO:0010467 | gene expression | 4 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 1 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031329 | regulation of cellular catabolic process | 5 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043487 | regulation of RNA stability | 3 | 1 |
GO:0043488 | regulation of mRNA stability | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044528 | regulation of mitochondrial mRNA stability | 5 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0061013 | regulation of mRNA catabolic process | 6 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065008 | regulation of biological quality | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:0140053 | mitochondrial gene expression | 5 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
GO:1903311 | regulation of mRNA metabolic process | 6 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:1900864 | mitochondrial RNA modification | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
GO:0003729 | mRNA binding | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 372 | 376 | PF00656 | 0.430 |
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.592 |
CLV_NRD_NRD_1 | 214 | 216 | PF00675 | 0.497 |
CLV_NRD_NRD_1 | 41 | 43 | PF00675 | 0.442 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.595 |
CLV_PCSK_KEX2_1 | 41 | 43 | PF00082 | 0.543 |
CLV_PCSK_SKI1_1 | 17 | 21 | PF00082 | 0.489 |
CLV_PCSK_SKI1_1 | 182 | 186 | PF00082 | 0.430 |
CLV_PCSK_SKI1_1 | 2 | 6 | PF00082 | 0.520 |
CLV_Separin_Metazoa | 44 | 48 | PF03568 | 0.529 |
DEG_APCC_DBOX_1 | 181 | 189 | PF00400 | 0.493 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.648 |
DEG_SPOP_SBC_1 | 477 | 481 | PF00917 | 0.413 |
DOC_CDC14_PxL_1 | 131 | 139 | PF14671 | 0.467 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 121 | 130 | PF00134 | 0.252 |
DOC_CYCLIN_yCln2_LP_2 | 257 | 263 | PF00134 | 0.358 |
DOC_MAPK_gen_1 | 47 | 57 | PF00069 | 0.403 |
DOC_MAPK_MEF2A_6 | 199 | 207 | PF00069 | 0.557 |
DOC_MAPK_MEF2A_6 | 439 | 446 | PF00069 | 0.433 |
DOC_PP1_RVXF_1 | 195 | 201 | PF00149 | 0.444 |
DOC_PP2B_LxvP_1 | 257 | 260 | PF13499 | 0.372 |
DOC_PP4_FxxP_1 | 200 | 203 | PF00568 | 0.399 |
DOC_USP7_MATH_1 | 342 | 346 | PF00917 | 0.268 |
DOC_USP7_MATH_1 | 420 | 424 | PF00917 | 0.452 |
DOC_USP7_MATH_1 | 440 | 444 | PF00917 | 0.272 |
DOC_USP7_MATH_1 | 477 | 481 | PF00917 | 0.553 |
DOC_USP7_MATH_1 | 68 | 72 | PF00917 | 0.438 |
DOC_USP7_UBL2_3 | 458 | 462 | PF12436 | 0.312 |
DOC_WW_Pin1_4 | 218 | 223 | PF00397 | 0.567 |
DOC_WW_Pin1_4 | 438 | 443 | PF00397 | 0.559 |
DOC_WW_Pin1_4 | 63 | 68 | PF00397 | 0.381 |
LIG_14-3-3_CanoR_1 | 113 | 121 | PF00244 | 0.398 |
LIG_14-3-3_CanoR_1 | 17 | 25 | PF00244 | 0.438 |
LIG_14-3-3_CanoR_1 | 286 | 294 | PF00244 | 0.321 |
LIG_14-3-3_CanoR_1 | 41 | 48 | PF00244 | 0.595 |
LIG_Actin_WH2_2 | 107 | 124 | PF00022 | 0.480 |
LIG_Actin_WH2_2 | 202 | 217 | PF00022 | 0.486 |
LIG_Actin_WH2_2 | 221 | 238 | PF00022 | 0.482 |
LIG_Actin_WH2_2 | 48 | 64 | PF00022 | 0.410 |
LIG_APCC_ABBA_1 | 424 | 429 | PF00400 | 0.521 |
LIG_eIF4E_1 | 395 | 401 | PF01652 | 0.478 |
LIG_FHA_1 | 146 | 152 | PF00498 | 0.468 |
LIG_FHA_1 | 202 | 208 | PF00498 | 0.452 |
LIG_FHA_1 | 285 | 291 | PF00498 | 0.476 |
LIG_FHA_1 | 41 | 47 | PF00498 | 0.307 |
LIG_FHA_1 | 430 | 436 | PF00498 | 0.514 |
LIG_FHA_1 | 439 | 445 | PF00498 | 0.590 |
LIG_FHA_1 | 64 | 70 | PF00498 | 0.372 |
LIG_FHA_1 | 89 | 95 | PF00498 | 0.497 |
LIG_FHA_2 | 206 | 212 | PF00498 | 0.434 |
LIG_FHA_2 | 225 | 231 | PF00498 | 0.299 |
LIG_FHA_2 | 35 | 41 | PF00498 | 0.581 |
LIG_FHA_2 | 458 | 464 | PF00498 | 0.486 |
LIG_HP1_1 | 181 | 185 | PF01393 | 0.268 |
LIG_LIR_Gen_1 | 128 | 137 | PF02991 | 0.338 |
LIG_LIR_Gen_1 | 230 | 238 | PF02991 | 0.343 |
LIG_LIR_Gen_1 | 344 | 354 | PF02991 | 0.364 |
LIG_LIR_Gen_1 | 381 | 388 | PF02991 | 0.350 |
LIG_LIR_Nem_3 | 128 | 134 | PF02991 | 0.335 |
LIG_LIR_Nem_3 | 230 | 235 | PF02991 | 0.326 |
LIG_LIR_Nem_3 | 240 | 246 | PF02991 | 0.334 |
LIG_LIR_Nem_3 | 344 | 349 | PF02991 | 0.380 |
LIG_LIR_Nem_3 | 352 | 357 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 381 | 386 | PF02991 | 0.353 |
LIG_LIR_Nem_3 | 398 | 404 | PF02991 | 0.536 |
LIG_LYPXL_yS_3 | 404 | 407 | PF13949 | 0.438 |
LIG_PTB_Apo_2 | 187 | 194 | PF02174 | 0.466 |
LIG_PTB_Apo_2 | 301 | 308 | PF02174 | 0.377 |
LIG_PTB_Phospho_1 | 187 | 193 | PF10480 | 0.468 |
LIG_PTB_Phospho_1 | 301 | 307 | PF10480 | 0.372 |
LIG_SH2_CRK | 167 | 171 | PF00017 | 0.382 |
LIG_SH2_PTP2 | 370 | 373 | PF00017 | 0.373 |
LIG_SH2_SRC | 370 | 373 | PF00017 | 0.496 |
LIG_SH2_STAP1 | 246 | 250 | PF00017 | 0.448 |
LIG_SH2_STAP1 | 307 | 311 | PF00017 | 0.405 |
LIG_SH2_STAP1 | 53 | 57 | PF00017 | 0.395 |
LIG_SH2_STAT3 | 48 | 51 | PF00017 | 0.514 |
LIG_SH2_STAT5 | 370 | 373 | PF00017 | 0.373 |
LIG_SH2_STAT5 | 395 | 398 | PF00017 | 0.430 |
LIG_SH2_STAT5 | 65 | 68 | PF00017 | 0.493 |
LIG_SH2_STAT5 | 75 | 78 | PF00017 | 0.473 |
LIG_SH3_3 | 158 | 164 | PF00018 | 0.512 |
LIG_SUMO_SIM_anti_2 | 225 | 230 | PF11976 | 0.367 |
LIG_SUMO_SIM_anti_2 | 54 | 60 | PF11976 | 0.353 |
LIG_SUMO_SIM_par_1 | 203 | 208 | PF11976 | 0.482 |
LIG_SUMO_SIM_par_1 | 221 | 227 | PF11976 | 0.257 |
LIG_TRAF2_1 | 385 | 388 | PF00917 | 0.404 |
LIG_WRC_WIRS_1 | 130 | 135 | PF05994 | 0.479 |
LIG_WRC_WIRS_1 | 343 | 348 | PF05994 | 0.271 |
LIG_WRC_WIRS_1 | 380 | 385 | PF05994 | 0.323 |
MOD_CK1_1 | 264 | 270 | PF00069 | 0.420 |
MOD_CK2_1 | 224 | 230 | PF00069 | 0.402 |
MOD_CK2_1 | 241 | 247 | PF00069 | 0.296 |
MOD_CK2_1 | 446 | 452 | PF00069 | 0.467 |
MOD_CK2_1 | 457 | 463 | PF00069 | 0.476 |
MOD_GlcNHglycan | 122 | 125 | PF01048 | 0.506 |
MOD_GlcNHglycan | 158 | 161 | PF01048 | 0.463 |
MOD_GSK3_1 | 15 | 22 | PF00069 | 0.434 |
MOD_GSK3_1 | 201 | 208 | PF00069 | 0.289 |
MOD_GSK3_1 | 218 | 225 | PF00069 | 0.497 |
MOD_GSK3_1 | 462 | 469 | PF00069 | 0.477 |
MOD_GSK3_1 | 472 | 479 | PF00069 | 0.569 |
MOD_NEK2_1 | 19 | 24 | PF00069 | 0.340 |
MOD_NEK2_1 | 205 | 210 | PF00069 | 0.423 |
MOD_NEK2_1 | 261 | 266 | PF00069 | 0.317 |
MOD_NEK2_1 | 356 | 361 | PF00069 | 0.356 |
MOD_NEK2_1 | 400 | 405 | PF00069 | 0.345 |
MOD_NEK2_1 | 446 | 451 | PF00069 | 0.624 |
MOD_NEK2_1 | 94 | 99 | PF00069 | 0.391 |
MOD_PIKK_1 | 395 | 401 | PF00454 | 0.355 |
MOD_PIKK_1 | 462 | 468 | PF00454 | 0.536 |
MOD_PIKK_1 | 75 | 81 | PF00454 | 0.370 |
MOD_PKA_2 | 285 | 291 | PF00069 | 0.324 |
MOD_PKA_2 | 40 | 46 | PF00069 | 0.314 |
MOD_Plk_1 | 462 | 468 | PF00069 | 0.422 |
MOD_Plk_1 | 94 | 100 | PF00069 | 0.409 |
MOD_Plk_2-3 | 310 | 316 | PF00069 | 0.418 |
MOD_Plk_4 | 173 | 179 | PF00069 | 0.388 |
MOD_Plk_4 | 20 | 26 | PF00069 | 0.394 |
MOD_Plk_4 | 201 | 207 | PF00069 | 0.275 |
MOD_Plk_4 | 224 | 230 | PF00069 | 0.328 |
MOD_Plk_4 | 261 | 267 | PF00069 | 0.312 |
MOD_Plk_4 | 335 | 341 | PF00069 | 0.460 |
MOD_Plk_4 | 440 | 446 | PF00069 | 0.499 |
MOD_ProDKin_1 | 218 | 224 | PF00069 | 0.563 |
MOD_ProDKin_1 | 438 | 444 | PF00069 | 0.552 |
MOD_ProDKin_1 | 63 | 69 | PF00069 | 0.376 |
MOD_SUMO_rev_2 | 443 | 451 | PF00179 | 0.585 |
MOD_SUMO_rev_2 | 54 | 64 | PF00179 | 0.434 |
TRG_DiLeu_BaEn_2 | 462 | 468 | PF01217 | 0.411 |
TRG_DiLeu_BaLyEn_6 | 246 | 251 | PF01217 | 0.417 |
TRG_DiLeu_LyEn_5 | 352 | 357 | PF01217 | 0.356 |
TRG_ENDOCYTIC_2 | 167 | 170 | PF00928 | 0.352 |
TRG_ENDOCYTIC_2 | 370 | 373 | PF00928 | 0.510 |
TRG_ENDOCYTIC_2 | 404 | 407 | PF00928 | 0.579 |
TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.600 |
TRG_Pf-PMV_PEXEL_1 | 236 | 240 | PF00026 | 0.512 |
TRG_Pf-PMV_PEXEL_1 | 249 | 253 | PF00026 | 0.321 |
TRG_Pf-PMV_PEXEL_1 | 50 | 54 | PF00026 | 0.363 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6Z9 | Leptomonas seymouri | 75% | 100% |
A0A0S4JM31 | Bodo saltans | 40% | 100% |
A0A1X0P8G7 | Trypanosomatidae | 54% | 100% |
A0A3Q8IIP3 | Leishmania donovani | 90% | 100% |
A0A3S5H691 | Leishmania donovani | 24% | 100% |
A0A422P283 | Trypanosoma rangeli | 52% | 100% |
A4H5F5 | Leishmania braziliensis | 23% | 100% |
A4HTQ0 | Leishmania infantum | 24% | 100% |
A4ICU3 | Leishmania infantum | 90% | 100% |
C9ZPF4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 25% | 93% |
D0A2L1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 100% |
E9AMI7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
E9ASG1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4Q234 | Leishmania major | 89% | 100% |
Q4QI52 | Leishmania major | 25% | 100% |
V5BQI6 | Trypanosoma cruzi | 52% | 100% |